ArticleRisk management and healthcare policy2026
Changes in Hospitalization Expenditures and Length of Stay for Patients Underwent Hysterectomy and Adnexectomy for Carcinoma in situ and Nonmalignant Lesions Diagnosis-Related Group: Impact of Beijing's Medicine-Consumables Linkage Reforms.
Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hysterectomy and adnexectomy for carcinoma in situ and nonmalignant lesions (HAC) is a subgroup of the diagnosis-related groups (DRG). A comprehensive set of reforms in Beijing, referred to as the medicine-consumables linkage (MCL) reforms, is intended to improve the quality of medical services. This study aims to analyze the impact of the MCL reforms on the changes in hospitalization expenditures, out-of-pocket (OOP) expenditures, and length of stay (LOS) for patients underwent HAC. Methods: We used an interrupted time series (ITS) model along with relevant data on HAC from January 2017 to December 2020 to analyze changes in hospitalization expenditures, OOP expenditures, and LOS for patients before and after the MCL reforms were implemented. Results: The results showed that after the reforms average surgical expenditures per hospitalization increased by 75.34%, whereas average examination and medical consumable expenditures per hospitalization decreased by 17.51% and 12.63%, respectively. The proportion of OOP expenditures decreased by 14.26%, and the average LOS per hospitalization decreased by 21.86%. The ITS analysis showed that the average total, laboratory test, drug, and OOP expenditures per hospitalization decreased monthly after the reforms. The impact of the reforms on the subgroup without comorbidity and complications was even more significant and reached the expected goals of the reforms. Conclusion: The hospitalization expenditure structure was optimized after the reforms, and the price of surgical services increased after the MCL reforms. The patients' cost burden was reduced, and the LOS for patients declined after the reforms. This study provides evidence and reference points for comparing hospitalization expenditures and the LOS for patients in optimizing DRG programs in China and other countries with similar hospitalization systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.